Used in biomedical research to detect and quantify glycogen phosphorylase isozyme BB levels in mouse samples, particularly in studies related to brain injury and neurodegeneration. The kit enables researchers to assess neuronal damage in experimental models, as GP-BB is released into the bloodstream following brain cell injury. It is commonly applied in stroke research, traumatic brain injury studies, and neuroprotective drug development. The ELISA format allows for high sensitivity and specificity, making it suitable for measuring low concentrations of GP-BB in serum, plasma, or tissue homogenates. This tool supports the evaluation of disease progression and treatment efficacy in preclinical neuroscience research.